Valeant Pharmaceuticals International Inc . has said that it will terminate its relationship with Philidor Rx Services . The decision comes after Bloomberg News ? reported ? that Philidor altered doctors prescriptions to wring more reimbursements out of U . S . health insurers . Valeant has lost almost 10 billion in market value after a Wall Street short seller suggested the company was using Philidor to engage in Enron style accounting practices . John Hempton , a hedge fund manager who has also long been critical of Valeant , thinks ? the company will likely now ? face ? litigation .
